Zobrazeno 1 - 10
of 459
pro vyhledávání: '"classic Hodgkin lymphoma"'
Publikováno v:
Health Economics Review, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Background Relapsed or refractory classic Hodgkin lymphoma (RRcHL) associates with poor prognosis and heavy disease burden to patients. This study evaluated the cost-effectiveness of brentuximab vedotin (BV) in comparison to conventional che
Externí odkaz:
https://doaj.org/article/565d114d5e3f47c6b9480d93b196dc4d
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 15, Iss , Pp 100303- (2024)
Classic Hodgkin lymphoma rarely undergoes pathological transformation, and the transformation type is usually common non-Hodgkin lymphoma. This study describes a 71-year-old male diagnosed with stage III classic Hodgkin lymphoma positive for Epstein
Externí odkaz:
https://doaj.org/article/87a67a9f5e1c4bcfac2151597488e718
Autor:
Ken Tanaka, Hiroaki Miyoshi, Yusuke Yamashita, Ryuta Iwamoto, Yuma Yokoya, Yuichi Tochino, Fumiko Arakawa, Shinobu Tamura, Shin-Ichi Murata, Takashi Sonoki, Koichi Ohshima
Publikováno v:
Hematology Reports, Vol 15, Iss 4, Pp 662-669 (2023)
We report a case of a 24-year-old man who developed angioimmunoblastic T-cell lymphoma (AITL) after treatment for refractory lymphocyte-rich classic Hodgkin lymphoma (LR-CHL). This patient was treated with the BV+AVD (brentuximab vedotin, doxorubicin
Externí odkaz:
https://doaj.org/article/4012cc9982094fbcac92fe7a8036bffe
Autor:
Dayeeta Bera, Dattatreya Roy
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Background Bone marrow cancer has been at the forefront of cancer research. The propensity of cancers to extravasate to the bone makes it a very relevant topic in the topology of this heterogeneous disease. Our narrative review article addre
Externí odkaz:
https://doaj.org/article/7b3bb79959944cc4accecaa24fa22035
Autor:
Stefano Pileri, Valentina Tabanelli, Roberto Chiarle, Angelica Calleri, Federica Melle, Giovanna Motta, Maria Rosaria Sapienza, Elena Sabattini, Pier Luigi Zinzani, Enrico Derenzini
Publikováno v:
Hemato, Vol 4, Iss 3, Pp 196-206 (2023)
The concept of gray-zone lymphoma (GZL) has been progressively refined since its introduction in the literature in 1998. For several years, it was applied to a rather broad spectrum of conditions, posing the problem of the differential diagnosis betw
Externí odkaz:
https://doaj.org/article/f8db9eaae74f414eabd0f815345ebeac
Autor:
Norihiro Ueda, Harumi Kato, Seiichi Kato, Toko Saito, Hiroyuki Tachibana, Masamitsu Yanada, Hirofumi Taji, Takeshi Kodaira, Waki Hosoda, Kazuhito Yamamoto
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTBackground No consensus has been reached yet concerning treatment strategies for a sequential classic Hodgkin lymphoma (CHL) following gray zone lymphoma (GZL). Prognosis of GZL after a failed autologous hematopoietic stem-cell transplantatio
Externí odkaz:
https://doaj.org/article/b4e3d4a9c1c64ab1b77d981e679662e7
Publikováno v:
Diagnostic Pathology, Vol 18, Iss 1, Pp 1-11 (2023)
Abstract Epstein-Barr virus (EBV) infection may present with fulminant constitutional symptoms, cytopenia(s), and systemic lymphadenopathy, raising clinical suspicion for lymphoma and prompting lymph node and bone marrow biopsies. At the microscopic
Externí odkaz:
https://doaj.org/article/3730c42b53874a739e2d3de14708157f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yuka Gion, Misato Doi, Yoshito Nishimura, Tomoka Ikeda, Midori Filiz Nishimura, Misa Sakamoto, Yuria Egusa, Asami Nishikori, Azusa Fujita, Noriko Iwaki, Naoya Nakamura, Tadashi Yoshino, Yasuharu Sato
Publikováno v:
Cancer Medicine, Vol 11, Iss 2, Pp 417-432 (2022)
Abstract Background Most patients with methotrexate‐associated lymphoproliferative disorder (MTX‐LPD) show diffuse large B‐cell lymphoma (DLBCL) or classic Hodgkin lymphoma (CHL) types. Patients with MTX‐LPD often have spontaneous remission a
Externí odkaz:
https://doaj.org/article/6e2da9f68eeb4074af0bba01de8c7953